{"transactions":[{"id":1488733,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE","position":1,"cik":"0001035443","reported_name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90213,"kind":"organization","name":"Alexandria Venture Investments, LLC","position":2,"cik":"0001722024","reported_name":"Alexandria Venture Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90214,"kind":"organization","name":"Alexandria Equities No. 7, LLC","position":3,"cik":"0001776437","reported_name":"Alexandria Equities No. 7, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-06-06T22:45:54.000Z","date":"2024-06-05","kind":"sale","planned":false,"acquired":false,"shares":150000,"price":4.24,"value":636000.0,"ownership":{"direct":false,"nature":"By subsidiary"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold at prices ranging from $4.10 to $4.40. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Alexandria Venture Investments, LLC, an affiliate of Alexandria Equities No. 7, LLC (\"AE7\"), and a wholly owned subsidiary of Alexandria Real Estate Equities, Inc."}],"balance_after":5855077,"source":{"system":"sec-edgar","filing":"0001035443-24-000171","document":"wk-form4_1717713946.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000103544324000171/wk-form4_1717713946.xml","form_type":"4"}},{"id":1488732,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE","position":1,"cik":"0001035443","reported_name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90213,"kind":"organization","name":"Alexandria Venture Investments, LLC","position":2,"cik":"0001722024","reported_name":"Alexandria Venture Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90214,"kind":"organization","name":"Alexandria Equities No. 7, LLC","position":3,"cik":"0001776437","reported_name":"Alexandria Equities No. 7, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-06-06T22:45:54.000Z","date":"2024-06-04","kind":"sale","planned":false,"acquired":false,"shares":150000,"price":4.21,"value":631500.0,"ownership":{"direct":false,"nature":"By subsidiary"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were sold at prices ranging from $4.12 to $4.32. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Alexandria Venture Investments, LLC, an affiliate of Alexandria Equities No. 7, LLC (\"AE7\"), and a wholly owned subsidiary of Alexandria Real Estate Equities, Inc."}],"balance_after":6005077,"source":{"system":"sec-edgar","filing":"0001035443-24-000171","document":"wk-form4_1717713946.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000103544324000171/wk-form4_1717713946.xml","form_type":"4"}},{"id":1725803,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE","position":1,"cik":"0001035443","reported_name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90214,"kind":"organization","name":"Alexandria Equities No. 7, LLC","position":2,"cik":"0001776437","reported_name":"Alexandria Equities No. 7, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90213,"kind":"organization","name":"Alexandria Venture Investments, LLC","position":3,"cik":"0001722024","reported_name":"Alexandria Venture Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-12-01T23:53:29.000Z","date":"2023-11-29","kind":"other","planned":false,"acquired":false,"shares":575000,"ownership":{"direct":false,"nature":"By subsidiary"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares have been transferred from Alexandria Equities No. 7, LLC, (\"AE7\") a wholly owned subsidiary of Alexandria Real Estate Equities, Inc. to Alexandria Venture Investments, LLC (\"AVI\"), another wholly owned subsidiary of Alexandria Real Estate Equities, Inc."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares have been transferred from Alexandria Equities No. 7, LLC, (\"AE7\") a wholly owned subsidiary of Alexandria Real Estate Equities, Inc. to Alexandria Venture Investments, LLC (\"AVI\"), another wholly owned subsidiary of Alexandria Real Estate Equities, Inc."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held directly by AE7, a wholly owned subsidiary of Alexandria Real Estate Equities, Inc."}],"balance_after":203977,"source":{"system":"sec-edgar","filing":"0001035443-23-000327","document":"wk-form4_1701474795.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000103544323000327/wk-form4_1701474795.xml","form_type":"4"}},{"id":1725802,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE","position":1,"cik":"0001035443","reported_name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90214,"kind":"organization","name":"Alexandria Equities No. 7, LLC","position":2,"cik":"0001776437","reported_name":"Alexandria Equities No. 7, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90213,"kind":"organization","name":"Alexandria Venture Investments, LLC","position":3,"cik":"0001722024","reported_name":"Alexandria Venture Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-12-01T23:53:29.000Z","date":"2023-11-29","kind":"other","planned":false,"acquired":true,"shares":575000,"ownership":{"direct":false,"nature":"By subsidiary"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares have been transferred from Alexandria Equities No. 7, LLC, (\"AE7\") a wholly owned subsidiary of Alexandria Real Estate Equities, Inc. to Alexandria Venture Investments, LLC (\"AVI\"), another wholly owned subsidiary of Alexandria Real Estate Equities, Inc."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares have been transferred from Alexandria Equities No. 7, LLC, (\"AE7\") a wholly owned subsidiary of Alexandria Real Estate Equities, Inc. to Alexandria Venture Investments, LLC (\"AVI\"), another wholly owned subsidiary of Alexandria Real Estate Equities, Inc."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by AVI, an affiliate of AE7 and another wholly owned subsidiary of Alexandria Real Estate Equities, Inc."}],"balance_after":6155077,"source":{"system":"sec-edgar","filing":"0001035443-23-000327","document":"wk-form4_1701474795.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000103544323000327/wk-form4_1701474795.xml","form_type":"4"}},{"id":1748885,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE","position":1,"cik":"0001035443","reported_name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90214,"kind":"organization","name":"Alexandria Equities No. 7, LLC","position":2,"cik":"0001776437","reported_name":"Alexandria Equities No. 7, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90213,"kind":"organization","name":"Alexandria Venture Investments, LLC","position":3,"cik":"0001722024","reported_name":"Alexandria Venture Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-11-06T21:56:09.000Z","date":"2023-11-03","kind":"sale","planned":false,"acquired":false,"shares":143450,"price":2.31,"value":331369.5,"ownership":{"direct":false,"nature":"By subsidiary"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold at prices ranging from $2.25 to $2.38. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Alexandria Venture Investments, LLC, an affiliate of Alexandria Equities No. 7, LLC (\"AE7\"), a wholly owned subsidiary of Alexandria Real Estate Equities, Inc."}],"balance_after":5580077,"source":{"system":"sec-edgar","filing":"0001035443-23-000315","document":"wk-form4_1699307758.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000103544323000315/wk-form4_1699307758.xml","form_type":"4"}},{"id":1748884,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE","position":1,"cik":"0001035443","reported_name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90214,"kind":"organization","name":"Alexandria Equities No. 7, LLC","position":2,"cik":"0001776437","reported_name":"Alexandria Equities No. 7, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90213,"kind":"organization","name":"Alexandria Venture Investments, LLC","position":3,"cik":"0001722024","reported_name":"Alexandria Venture Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-11-06T21:56:09.000Z","date":"2023-11-02","kind":"sale","planned":false,"acquired":false,"shares":103808,"price":2.32,"value":240834.56,"ownership":{"direct":false,"nature":"By subsidiary"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were sold at prices ranging from $2.30 to $2.39. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Alexandria Venture Investments, LLC, an affiliate of Alexandria Equities No. 7, LLC (\"AE7\"), a wholly owned subsidiary of Alexandria Real Estate Equities, Inc."}],"balance_after":5723527,"source":{"system":"sec-edgar","filing":"0001035443-23-000315","document":"wk-form4_1699307758.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000103544323000315/wk-form4_1699307758.xml","form_type":"4"}},{"id":1751533,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE","position":1,"cik":"0001035443","reported_name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90213,"kind":"organization","name":"Alexandria Venture Investments, LLC","position":2,"cik":"0001722024","reported_name":"Alexandria Venture Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90214,"kind":"organization","name":"Alexandria Equities No. 7, LLC","position":3,"cik":"0001776437","reported_name":"Alexandria Equities No. 7, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-11-02T20:44:31.000Z","date":"2023-11-01","kind":"sale","planned":false,"acquired":false,"shares":172742,"price":2.36,"value":407671.12,"ownership":{"direct":false,"nature":"By subsidiary"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold at prices ranging from $2.32 to $2.46.  The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Alexandria Venture Investments, LLC, an affiliate of Alexandria Equities No. 7, LLC (\"AE7\"), a wholly owned subsidiary of Alexandria Real Estate Equities, Inc."}],"balance_after":5827335,"source":{"system":"sec-edgar","filing":"0001035443-23-000308","document":"wk-form4_1698957861.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000103544323000308/wk-form4_1698957861.xml","form_type":"4"}},{"id":1751532,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE","position":1,"cik":"0001035443","reported_name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90213,"kind":"organization","name":"Alexandria Venture Investments, LLC","position":2,"cik":"0001722024","reported_name":"Alexandria Venture Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90214,"kind":"organization","name":"Alexandria Equities No. 7, LLC","position":3,"cik":"0001776437","reported_name":"Alexandria Equities No. 7, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-11-02T20:44:31.000Z","date":"2023-10-31","kind":"sale","planned":false,"acquired":false,"shares":155000,"price":2.41,"value":373550.0,"ownership":{"direct":false,"nature":"By subsidiary"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were sold at prices ranging from $2.40 to $2.47.  The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Alexandria Venture Investments, LLC, an affiliate of Alexandria Equities No. 7, LLC (\"AE7\"), a wholly owned subsidiary of Alexandria Real Estate Equities, Inc."}],"balance_after":6000077,"source":{"system":"sec-edgar","filing":"0001035443-23-000308","document":"wk-form4_1698957861.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000103544323000308/wk-form4_1698957861.xml","form_type":"4"}},{"id":1759988,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE","position":1,"cik":"0001035443","reported_name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90213,"kind":"organization","name":"Alexandria Venture Investments, LLC","position":2,"cik":"0001722024","reported_name":"Alexandria Venture Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90214,"kind":"organization","name":"Alexandria Equities No. 7, LLC","position":3,"cik":"0001776437","reported_name":"Alexandria Equities No. 7, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Pre-Funded Warrant","published_at":"2023-10-16T23:17:08.000Z","date":"2023-10-12","kind":"other","planned":false,"acquired":false,"shares":615000,"ownership":{"direct":false,"nature":"By subsidiary"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The Pre-Funded Warrants are exercisable immediately and will expire five years from the date of issuance. The Pre-Funded Warrants may not be exercised to the extent such exercise would cause the holder (together with its affiliates, any other persons acting as a group together with the holder or any of the holder's affiliates, and any other persons whose beneficial ownership of the Issuer's common stock would or could be aggregated with the holder's for purposes of Section 13(d) or Section 16 of the Securities Exchange Act of 1934, as amended) to beneficially own more than 19.99% of the Issuer's common stock outstanding immediately after giving effect to such exercise."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares have been transferred from Alexandria Equities No. 7, LLC (\"AE7\"), a wholly owned subsidiary of Alexandria Real Estate Equities, Inc. to Alexandria Venture Investments, LLC (\"AVI\"), an\naffiliate of AE7 and another wholly owned subsidiary of Alexandria Real Estate Equities, Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Pre-Funded Warrants are exercisable immediately and will expire five years from the date of issuance. The Pre-Funded Warrants may not be exercised to the extent such exercise would cause the holder (together with its affiliates, any other persons acting as a group together with the holder or any of the holder's affiliates, and any other persons whose beneficial ownership of the Issuer's common stock would or could be aggregated with the holder's for purposes of Section 13(d) or Section 16 of the Securities Exchange Act of 1934, as amended) to beneficially own more than 19.99% of the Issuer's common stock outstanding immediately after giving effect to such exercise."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Pre-Funded Warrants are exercisable immediately and will expire five years from the date of issuance. The Pre-Funded Warrants may not be exercised to the extent such exercise would cause the holder (together with its affiliates, any other persons acting as a group together with the holder or any of the holder's affiliates, and any other persons whose beneficial ownership of the Issuer's common stock would or could be aggregated with the holder's for purposes of Section 13(d) or Section 16 of the Securities Exchange Act of 1934, as amended) to beneficially own more than 19.99% of the Issuer's common stock outstanding immediately after giving effect to such exercise."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held directly by Alexandria Equities No. 7, LLC (\"AE7\"), a wholly owned subsidiary of Alexandria Real Estate Equities, Inc."}],"balance_after":0,"derivative":{"exercise_price":0.0001,"underlying":"Common Stock","underlying_shares":0},"source":{"system":"sec-edgar","filing":"0001035443-23-000283","document":"wk-form4_1697498217.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000103544323000283/wk-form4_1697498217.xml","form_type":"4"}},{"id":1759987,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE","position":1,"cik":"0001035443","reported_name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90213,"kind":"organization","name":"Alexandria Venture Investments, LLC","position":2,"cik":"0001722024","reported_name":"Alexandria Venture Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90214,"kind":"organization","name":"Alexandria Equities No. 7, LLC","position":3,"cik":"0001776437","reported_name":"Alexandria Equities No. 7, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Pre-Funded Warrant","published_at":"2023-10-16T23:17:08.000Z","date":"2023-10-12","kind":"other","planned":false,"acquired":true,"shares":615000,"ownership":{"direct":false,"nature":"By subidiary"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The Pre-Funded Warrants are exercisable immediately and will expire five years from the date of issuance. The Pre-Funded Warrants may not be exercised to the extent such exercise would cause the holder (together with its affiliates, any other persons acting as a group together with the holder or any of the holder's affiliates, and any other persons whose beneficial ownership of the Issuer's common stock would or could be aggregated with the holder's for purposes of Section 13(d) or Section 16 of the Securities Exchange Act of 1934, as amended) to beneficially own more than 19.99% of the Issuer's common stock outstanding immediately after giving effect to such exercise."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares have been transferred from Alexandria Equities No. 7, LLC (\"AE7\"), a wholly owned subsidiary of Alexandria Real Estate Equities, Inc. to Alexandria Venture Investments, LLC (\"AVI\"), an\naffiliate of AE7 and another wholly owned subsidiary of Alexandria Real Estate Equities, Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Pre-Funded Warrants are exercisable immediately and will expire five years from the date of issuance. The Pre-Funded Warrants may not be exercised to the extent such exercise would cause the holder (together with its affiliates, any other persons acting as a group together with the holder or any of the holder's affiliates, and any other persons whose beneficial ownership of the Issuer's common stock would or could be aggregated with the holder's for purposes of Section 13(d) or Section 16 of the Securities Exchange Act of 1934, as amended) to beneficially own more than 19.99% of the Issuer's common stock outstanding immediately after giving effect to such exercise."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Pre-Funded Warrants are exercisable immediately and will expire five years from the date of issuance. The Pre-Funded Warrants may not be exercised to the extent such exercise would cause the holder (together with its affiliates, any other persons acting as a group together with the holder or any of the holder's affiliates, and any other persons whose beneficial ownership of the Issuer's common stock would or could be aggregated with the holder's for purposes of Section 13(d) or Section 16 of the Securities Exchange Act of 1934, as amended) to beneficially own more than 19.99% of the Issuer's common stock outstanding immediately after giving effect to such exercise."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Alexandria Venture Investments, LLC (\"AVI\"), an affiliate of AE7 and another wholly owned subsidiary of Alexandria Real Estate Equities, Inc."}],"balance_after":1500000,"derivative":{"exercise_price":0.0001,"underlying":"Common Stock","underlying_shares":615000},"source":{"system":"sec-edgar","filing":"0001035443-23-000283","document":"wk-form4_1697498217.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000103544323000283/wk-form4_1697498217.xml","form_type":"4"}},{"id":1759986,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE","position":1,"cik":"0001035443","reported_name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90213,"kind":"organization","name":"Alexandria Venture Investments, LLC","position":2,"cik":"0001722024","reported_name":"Alexandria Venture Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90214,"kind":"organization","name":"Alexandria Equities No. 7, LLC","position":3,"cik":"0001776437","reported_name":"Alexandria Equities No. 7, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-10-16T23:17:08.000Z","date":"2023-10-12","kind":"other","planned":false,"acquired":false,"shares":1600000,"ownership":{"direct":false,"nature":"By subsidiary"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares have been transferred from Alexandria Equities No. 7, LLC (\"AE7\"), a wholly owned subsidiary of Alexandria Real Estate Equities, Inc. to Alexandria Venture Investments, LLC (\"AVI\"), an\naffiliate of AE7 and another wholly owned subsidiary of Alexandria Real Estate Equities, Inc."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares have been transferred from Alexandria Equities No. 7, LLC (\"AE7\"), a wholly owned subsidiary of Alexandria Real Estate Equities, Inc. to Alexandria Venture Investments, LLC (\"AVI\"), an\naffiliate of AE7 and another wholly owned subsidiary of Alexandria Real Estate Equities, Inc."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held directly by Alexandria Equities No. 7, LLC (\"AE7\"), a wholly owned subsidiary of Alexandria Real Estate Equities, Inc."}],"balance_after":778977,"source":{"system":"sec-edgar","filing":"0001035443-23-000283","document":"wk-form4_1697498217.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000103544323000283/wk-form4_1697498217.xml","form_type":"4"}},{"id":1759985,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE","position":1,"cik":"0001035443","reported_name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90213,"kind":"organization","name":"Alexandria Venture Investments, LLC","position":2,"cik":"0001722024","reported_name":"Alexandria Venture Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90214,"kind":"organization","name":"Alexandria Equities No. 7, LLC","position":3,"cik":"0001776437","reported_name":"Alexandria Equities No. 7, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-10-16T23:17:08.000Z","date":"2023-10-12","kind":"other","planned":false,"acquired":true,"shares":1600000,"ownership":{"direct":false,"nature":"By subsidiary"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares have been transferred from Alexandria Equities No. 7, LLC (\"AE7\"), a wholly owned subsidiary of Alexandria Real Estate Equities, Inc. to Alexandria Venture Investments, LLC (\"AVI\"), an\naffiliate of AE7 and another wholly owned subsidiary of Alexandria Real Estate Equities, Inc."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares have been transferred from Alexandria Equities No. 7, LLC (\"AE7\"), a wholly owned subsidiary of Alexandria Real Estate Equities, Inc. to Alexandria Venture Investments, LLC (\"AVI\"), an\naffiliate of AE7 and another wholly owned subsidiary of Alexandria Real Estate Equities, Inc."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Alexandria Venture Investments, LLC (\"AVI\"), an affiliate of AE7 and another wholly owned subsidiary of Alexandria Real Estate Equities, Inc."}],"balance_after":6155077,"source":{"system":"sec-edgar","filing":"0001035443-23-000283","document":"wk-form4_1697498217.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000103544323000283/wk-form4_1697498217.xml","form_type":"4"}},{"id":1822972,"issuer":{"id":111075,"kind":"organization","name":"GreenLight Biosciences Holdings, PBC","symbol":"GRNA"},"owners":[{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE","position":1,"cik":"0001035443","reported_name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}},{"id":90213,"kind":"organization","name":"Alexandria Venture Investments, LLC","position":2,"cik":"0001722024","reported_name":"Alexandria Venture Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2023-07-26T20:30:07.000Z","date":"2023-07-24","kind":"other","planned":false,"acquired":false,"shares":1609909,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Alexandria Venture Investments, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On July 24, 2023, SW MergerCo, Inc. (\"Merger Sub\") and SW ParentCo, Inc. (\"Parent\") completed the merger (the \"Merger\") with and into the Issuer, pursuant to the terms of the Agreement and Plan of Merger, dated as of May 29, 2023, by and among Parent, Merger Sub and the Issuer. In connection with the completion of the Merger, Alexandria Venture Investments, LLC (\"AVI\") contributed all of the shares of Common Stock held by AVI (the \"Rollover Shares\") to Parent in exchange for equity interests of Parent. At the effective time of the Merger, each of the Rollover Shares were canceled and ceased to exist and no consideration was paid in respect of such Rollover Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 24, 2023, SW MergerCo, Inc. (\"Merger Sub\") and SW ParentCo, Inc. (\"Parent\") completed the merger (the \"Merger\") with and into the Issuer, pursuant to the terms of the Agreement and Plan of Merger, dated as of May 29, 2023, by and among Parent, Merger Sub and the Issuer. In connection with the completion of the Merger, Alexandria Venture Investments, LLC (\"AVI\") contributed all of the shares of Common Stock held by AVI (the \"Rollover Shares\") to Parent in exchange for equity interests of Parent. At the effective time of the Merger, each of the Rollover Shares were canceled and ceased to exist and no consideration was paid in respect of such Rollover Shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Alexandria Venture Investments, LLC, a wholly owned subsidiary of Alexandria Real Estate Equities, Inc."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-043416","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000120919123043416/doc4.xml","form_type":"4"}},{"id":2219550,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE","position":1,"cik":"0001035443","reported_name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90213,"kind":"organization","name":"Alexandria Venture Investments, LLC","position":2,"cik":"0001722024","reported_name":"Alexandria Venture Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90214,"kind":"organization","name":"Alexandria Equities No. 7, LLC","position":3,"cik":"0001776437","reported_name":"Alexandria Equities No. 7, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock Warrant","published_at":"2022-06-29T20:37:37.000Z","date":"2022-06-27","kind":"purchase","acquired":true,"shares":2950000,"ownership":{"direct":false,"nature":"By subsidiary"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These securities were purchased at a combined public offering price of $1.00 per share of Common Stock and associated Common Stock Warrant (or, in the case of the Pre-Funded Warrants, $0.9999 per Pre-Funded Warrant and associated Common Stock Warrant)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Common Stock Warrants are exercisable immediately and will expire five years from the date of issuance. The Common Stock Warrants may not be exercised to the extent such exercise would cause the holder (together with its affiliates, any other persons acting as a group together with the holder or any of the holder's affiliates, and any other persons whose beneficial ownership of the Issuer's common stock would or could be aggregated with the holder's for purposes of Section 13(d) or Section 16 of the Securities Exchange Act of 1934, as amended) to beneficially own more than 19.99% of the Issuer's common stock outstanding immediately after giving effect to such exercise."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Common Stock Warrants are exercisable immediately and will expire five years from the date of issuance. The Common Stock Warrants may not be exercised to the extent such exercise would cause the holder (together with its affiliates, any other persons acting as a group together with the holder or any of the holder's affiliates, and any other persons whose beneficial ownership of the Issuer's common stock would or could be aggregated with the holder's for purposes of Section 13(d) or Section 16 of the Securities Exchange Act of 1934, as amended) to beneficially own more than 19.99% of the Issuer's common stock outstanding immediately after giving effect to such exercise."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held directly by Alexandria Venture Investments, LLC (\"AVI\"), an affiliate of AE7 and another wholly owned subsidiary of Alexandria Real Estate Equities, Inc."}],"balance_after":2950000,"derivative":{"exercise_price":1,"underlying":"Common Stock","underlying_shares":2950000},"source":{"system":"sec-edgar","filing":"0001035443-22-000176","document":"wf-form4_165653503462000.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000103544322000176/wf-form4_165653503462000.xml","form_type":"4"}},{"id":2219549,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE","position":1,"cik":"0001035443","reported_name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90213,"kind":"organization","name":"Alexandria Venture Investments, LLC","position":2,"cik":"0001722024","reported_name":"Alexandria Venture Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90214,"kind":"organization","name":"Alexandria Equities No. 7, LLC","position":3,"cik":"0001776437","reported_name":"Alexandria Equities No. 7, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock Warrant","published_at":"2022-06-29T20:37:37.000Z","date":"2022-06-27","kind":"purchase","acquired":true,"shares":2050000,"ownership":{"direct":false,"nature":"By subsidiary"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These securities were purchased at a combined public offering price of $1.00 per share of Common Stock and associated Common Stock Warrant (or, in the case of the Pre-Funded Warrants, $0.9999 per Pre-Funded Warrant and associated Common Stock Warrant)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Common Stock Warrants are exercisable immediately and will expire five years from the date of issuance. The Common Stock Warrants may not be exercised to the extent such exercise would cause the holder (together with its affiliates, any other persons acting as a group together with the holder or any of the holder's affiliates, and any other persons whose beneficial ownership of the Issuer's common stock would or could be aggregated with the holder's for purposes of Section 13(d) or Section 16 of the Securities Exchange Act of 1934, as amended) to beneficially own more than 19.99% of the Issuer's common stock outstanding immediately after giving effect to such exercise."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Common Stock Warrants are exercisable immediately and will expire five years from the date of issuance. The Common Stock Warrants may not be exercised to the extent such exercise would cause the holder (together with its affiliates, any other persons acting as a group together with the holder or any of the holder's affiliates, and any other persons whose beneficial ownership of the Issuer's common stock would or could be aggregated with the holder's for purposes of Section 13(d) or Section 16 of the Securities Exchange Act of 1934, as amended) to beneficially own more than 19.99% of the Issuer's common stock outstanding immediately after giving effect to such exercise."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Alexandria Equities No. 7, LLC (\"AE7\"), a wholly owned subsidiary of Alexandria Real Estate Equities, Inc."}],"balance_after":2050000,"derivative":{"exercise_price":1,"underlying":"Common Stock","underlying_shares":2050000},"source":{"system":"sec-edgar","filing":"0001035443-22-000176","document":"wf-form4_165653503462000.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000103544322000176/wf-form4_165653503462000.xml","form_type":"4"}},{"id":2219548,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE","position":1,"cik":"0001035443","reported_name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90213,"kind":"organization","name":"Alexandria Venture Investments, LLC","position":2,"cik":"0001722024","reported_name":"Alexandria Venture Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90214,"kind":"organization","name":"Alexandria Equities No. 7, LLC","position":3,"cik":"0001776437","reported_name":"Alexandria Equities No. 7, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Pre-Funded Warrant","published_at":"2022-06-29T20:37:37.000Z","date":"2022-06-27","kind":"purchase","acquired":true,"shares":885000,"price":0.9999,"value":884911.5,"ownership":{"direct":false,"nature":"By subidiary"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These securities were purchased at a combined public offering price of $1.00 per share of Common Stock and associated Common Stock Warrant (or, in the case of the Pre-Funded Warrants, $0.9999 per Pre-Funded Warrant and associated Common Stock Warrant)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Pre-Funded Warrants are exercisable immediately and will expire five years from the date of issuance. The Pre-Funded Warrants may not be exercised to the extent such exercise would cause the holder (together with its affiliates, any other persons acting as a group together with the holder or any of the holder's affiliates, and any other persons whose beneficial ownership of the Issuer's common stock would or could be aggregated with the holder's for purposes of Section 13(d) or Section 16 of the Securities Exchange Act of 1934, as amended) to beneficially own more than 19.99% of the Issuer's common stock outstanding immediately after giving effect to such exercise."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Pre-Funded Warrants are exercisable immediately and will expire five years from the date of issuance. The Pre-Funded Warrants may not be exercised to the extent such exercise would cause the holder (together with its affiliates, any other persons acting as a group together with the holder or any of the holder's affiliates, and any other persons whose beneficial ownership of the Issuer's common stock would or could be aggregated with the holder's for purposes of Section 13(d) or Section 16 of the Securities Exchange Act of 1934, as amended) to beneficially own more than 19.99% of the Issuer's common stock outstanding immediately after giving effect to such exercise."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held directly by Alexandria Venture Investments, LLC (\"AVI\"), an affiliate of AE7 and another wholly owned subsidiary of Alexandria Real Estate Equities, Inc."}],"balance_after":885000,"derivative":{"exercise_price":0.0001,"underlying":"Common Stock","underlying_shares":885000},"source":{"system":"sec-edgar","filing":"0001035443-22-000176","document":"wf-form4_165653503462000.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000103544322000176/wf-form4_165653503462000.xml","form_type":"4"}},{"id":2219547,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE","position":1,"cik":"0001035443","reported_name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90213,"kind":"organization","name":"Alexandria Venture Investments, LLC","position":2,"cik":"0001722024","reported_name":"Alexandria Venture Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90214,"kind":"organization","name":"Alexandria Equities No. 7, LLC","position":3,"cik":"0001776437","reported_name":"Alexandria Equities No. 7, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Pre-Funded Warrant","published_at":"2022-06-29T20:37:37.000Z","date":"2022-06-27","kind":"purchase","acquired":true,"shares":615000,"price":0.9999,"value":614938.5,"ownership":{"direct":false,"nature":"By subsidiary"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These securities were purchased at a combined public offering price of $1.00 per share of Common Stock and associated Common Stock Warrant (or, in the case of the Pre-Funded Warrants, $0.9999 per Pre-Funded Warrant and associated Common Stock Warrant)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Pre-Funded Warrants are exercisable immediately and will expire five years from the date of issuance. The Pre-Funded Warrants may not be exercised to the extent such exercise would cause the holder (together with its affiliates, any other persons acting as a group together with the holder or any of the holder's affiliates, and any other persons whose beneficial ownership of the Issuer's common stock would or could be aggregated with the holder's for purposes of Section 13(d) or Section 16 of the Securities Exchange Act of 1934, as amended) to beneficially own more than 19.99% of the Issuer's common stock outstanding immediately after giving effect to such exercise."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Pre-Funded Warrants are exercisable immediately and will expire five years from the date of issuance. The Pre-Funded Warrants may not be exercised to the extent such exercise would cause the holder (together with its affiliates, any other persons acting as a group together with the holder or any of the holder's affiliates, and any other persons whose beneficial ownership of the Issuer's common stock would or could be aggregated with the holder's for purposes of Section 13(d) or Section 16 of the Securities Exchange Act of 1934, as amended) to beneficially own more than 19.99% of the Issuer's common stock outstanding immediately after giving effect to such exercise."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Alexandria Equities No. 7, LLC (\"AE7\"), a wholly owned subsidiary of Alexandria Real Estate Equities, Inc."}],"balance_after":615000,"derivative":{"exercise_price":0.0001,"underlying":"Common Stock","underlying_shares":615000},"source":{"system":"sec-edgar","filing":"0001035443-22-000176","document":"wf-form4_165653503462000.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000103544322000176/wf-form4_165653503462000.xml","form_type":"4"}},{"id":2219546,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE","position":1,"cik":"0001035443","reported_name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90213,"kind":"organization","name":"Alexandria Venture Investments, LLC","position":2,"cik":"0001722024","reported_name":"Alexandria Venture Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90214,"kind":"organization","name":"Alexandria Equities No. 7, LLC","position":3,"cik":"0001776437","reported_name":"Alexandria Equities No. 7, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-06-29T20:37:37.000Z","date":"2022-06-27","kind":"purchase","acquired":true,"shares":2065000,"price":1,"value":2065000.0,"ownership":{"direct":false,"nature":"By subsidiary"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These securities were purchased at a combined public offering price of $1.00 per share of Common Stock and associated Common Stock Warrant (or, in the case of the Pre-Funded Warrants, $0.9999 per Pre-Funded Warrant and associated Common Stock Warrant)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held directly by Alexandria Venture Investments, LLC (\"AVI\"), an affiliate of AE7 and another wholly owned subsidiary of Alexandria Real Estate Equities, Inc."}],"balance_after":4555077,"source":{"system":"sec-edgar","filing":"0001035443-22-000176","document":"wf-form4_165653503462000.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000103544322000176/wf-form4_165653503462000.xml","form_type":"4"}},{"id":2219545,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE","position":1,"cik":"0001035443","reported_name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90213,"kind":"organization","name":"Alexandria Venture Investments, LLC","position":2,"cik":"0001722024","reported_name":"Alexandria Venture Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90214,"kind":"organization","name":"Alexandria Equities No. 7, LLC","position":3,"cik":"0001776437","reported_name":"Alexandria Equities No. 7, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-06-29T20:37:37.000Z","date":"2022-06-27","kind":"purchase","acquired":true,"shares":1435000,"price":1,"value":1435000.0,"ownership":{"direct":false,"nature":"By subsidiary"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These securities were purchased at a combined public offering price of $1.00 per share of Common Stock and associated Common Stock Warrant (or, in the case of the Pre-Funded Warrants, $0.9999 per Pre-Funded Warrant and associated Common Stock Warrant)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Alexandria Equities No. 7, LLC (\"AE7\"), a wholly owned subsidiary of Alexandria Real Estate Equities, Inc."}],"balance_after":2378977,"source":{"system":"sec-edgar","filing":"0001035443-22-000176","document":"wf-form4_165653503462000.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000103544322000176/wf-form4_165653503462000.xml","form_type":"4"}},{"id":2372697,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE","position":1,"cik":"0001035443","reported_name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90213,"kind":"organization","name":"Alexandria Venture Investments, LLC","position":2,"cik":"0001722024","reported_name":"Alexandria Venture Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90214,"kind":"organization","name":"Alexandria Equities No. 7, LLC","position":3,"cik":"0001776437","reported_name":"Alexandria Equities No. 7, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-02-25T21:52:55.000Z","date":"2022-02-23","kind":"other","acquired":false,"shares":300000,"ownership":{"direct":false,"nature":"By subsidiary"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares have been transferred from Alexandria Equities No. 7, LLC (\"AE7\"), a wholly owned subsidiary of Alexandria Real Estate Equities, Inc. to Alexandria Venture Investments, LLC (\"AVI\"), an affiliate of AE7 and another wholly owned subsidiary of Alexandria Real Estate Equities, Inc."},{"field":"shares","element":"transactionShares","label":"F1","text":"These shares have been transferred from Alexandria Equities No. 7, LLC (\"AE7\"), a wholly owned subsidiary of Alexandria Real Estate Equities, Inc. to Alexandria Venture Investments, LLC (\"AVI\"), an affiliate of AE7 and another wholly owned subsidiary of Alexandria Real Estate Equities, Inc."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares have been transferred from Alexandria Equities No. 7, LLC (\"AE7\"), a wholly owned subsidiary of Alexandria Real Estate Equities, Inc. to Alexandria Venture Investments, LLC (\"AVI\"), an affiliate of AE7 and another wholly owned subsidiary of Alexandria Real Estate Equities, Inc."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held directly by AE7."}],"balance_after":943977,"source":{"system":"sec-edgar","filing":"0001035443-22-000066","document":"wf-form4_164582594767959.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000103544322000066/wf-form4_164582594767959.xml","form_type":"4"}},{"id":2372696,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE","position":1,"cik":"0001035443","reported_name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90213,"kind":"organization","name":"Alexandria Venture Investments, LLC","position":2,"cik":"0001722024","reported_name":"Alexandria Venture Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90214,"kind":"organization","name":"Alexandria Equities No. 7, LLC","position":3,"cik":"0001776437","reported_name":"Alexandria Equities No. 7, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-02-25T21:52:55.000Z","date":"2022-02-23","kind":"other","acquired":true,"shares":300000,"ownership":{"direct":false,"nature":"By subsidiary"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares have been transferred from Alexandria Equities No. 7, LLC (\"AE7\"), a wholly owned subsidiary of Alexandria Real Estate Equities, Inc. to Alexandria Venture Investments, LLC (\"AVI\"), an affiliate of AE7 and another wholly owned subsidiary of Alexandria Real Estate Equities, Inc."},{"field":"shares","element":"transactionShares","label":"F1","text":"These shares have been transferred from Alexandria Equities No. 7, LLC (\"AE7\"), a wholly owned subsidiary of Alexandria Real Estate Equities, Inc. to Alexandria Venture Investments, LLC (\"AVI\"), an affiliate of AE7 and another wholly owned subsidiary of Alexandria Real Estate Equities, Inc."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares have been transferred from Alexandria Equities No. 7, LLC (\"AE7\"), a wholly owned subsidiary of Alexandria Real Estate Equities, Inc. to Alexandria Venture Investments, LLC (\"AVI\"), an affiliate of AE7 and another wholly owned subsidiary of Alexandria Real Estate Equities, Inc."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by AVI."}],"balance_after":2490077,"source":{"system":"sec-edgar","filing":"0001035443-22-000066","document":"wf-form4_164582594767959.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000103544322000066/wf-form4_164582594767959.xml","form_type":"4"}},{"id":2846749,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE","position":1,"cik":"0001035443","reported_name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90214,"kind":"organization","name":"Alexandria Equities No. 7, LLC","position":2,"cik":"0001776437","reported_name":"Alexandria Equities No. 7, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90213,"kind":"organization","name":"Alexandria Venture Investments, LLC","position":3,"cik":"0001722024","reported_name":"Alexandria Venture Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-02-19T22:17:05.000Z","date":"2021-02-17","kind":"other","acquired":true,"shares":43478,"ownership":{"direct":false,"nature":"By subsidiary"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares have been transferred from AE7 to Alexandria Venture Investments, LLC (\"AVI\") upon acquisition, an affiliate of AE7 and another wholly owned subsidiary of Alexandria Real Estate Equities, Inc."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares have been transferred from AE7 to Alexandria Venture Investments, LLC (\"AVI\") upon acquisition, an affiliate of AE7 and another wholly owned subsidiary of Alexandria Real Estate Equities, Inc."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held directly by AVI."}],"balance_after":2190077,"source":{"system":"sec-edgar","filing":"0001035443-21-000049","document":"wf-form4_161377301066645.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000103544321000049/wf-form4_161377301066645.xml","form_type":"4"}},{"id":2846748,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE","position":1,"cik":"0001035443","reported_name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90214,"kind":"organization","name":"Alexandria Equities No. 7, LLC","position":2,"cik":"0001776437","reported_name":"Alexandria Equities No. 7, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90213,"kind":"organization","name":"Alexandria Venture Investments, LLC","position":3,"cik":"0001722024","reported_name":"Alexandria Venture Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-02-19T22:17:05.000Z","date":"2021-02-17","kind":"other","acquired":false,"shares":43478,"ownership":{"direct":false,"nature":"By subsidiary"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares have been transferred from AE7 to Alexandria Venture Investments, LLC (\"AVI\") upon acquisition, an affiliate of AE7 and another wholly owned subsidiary of Alexandria Real Estate Equities, Inc."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares have been transferred from AE7 to Alexandria Venture Investments, LLC (\"AVI\") upon acquisition, an affiliate of AE7 and another wholly owned subsidiary of Alexandria Real Estate Equities, Inc."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held directly by Alexandria Equities No. 7, LLC (\"AE7\"), a wholly owned subsidiary of Alexandria Real Estate Equities, Inc."}],"balance_after":1243977,"source":{"system":"sec-edgar","filing":"0001035443-21-000049","document":"wf-form4_161377301066645.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000103544321000049/wf-form4_161377301066645.xml","form_type":"4"}},{"id":2846747,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE","position":1,"cik":"0001035443","reported_name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90214,"kind":"organization","name":"Alexandria Equities No. 7, LLC","position":2,"cik":"0001776437","reported_name":"Alexandria Equities No. 7, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90213,"kind":"organization","name":"Alexandria Venture Investments, LLC","position":3,"cik":"0001722024","reported_name":"Alexandria Venture Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-02-19T22:17:05.000Z","date":"2021-02-17","kind":"purchase","acquired":true,"shares":43478,"price":23,"value":999994.0,"ownership":{"direct":false,"nature":"By subsidiary"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held directly by Alexandria Equities No. 7, LLC (\"AE7\"), a wholly owned subsidiary of Alexandria Real Estate Equities, Inc."}],"balance_after":1287455,"source":{"system":"sec-edgar","filing":"0001035443-21-000049","document":"wf-form4_161377301066645.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000103544321000049/wf-form4_161377301066645.xml","form_type":"4"}},{"id":3191235,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE","position":1,"cik":"0001035443","reported_name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90213,"kind":"organization","name":"Alexandria Venture Investments, LLC","position":2,"cik":"0001722024","reported_name":"Alexandria Venture Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90214,"kind":"organization","name":"Alexandria Equities No. 7, LLC","position":3,"cik":"0001776437","reported_name":"Alexandria Equities No. 7, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-03-31T20:38:04.000Z","date":"2020-03-27","kind":"other","acquired":false,"shares":975000,"ownership":{"direct":false,"nature":"By subsidiary"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares have been transferred from Alexandria Equities No. 7, LLC (\"AE7\"), a wholly owned subsidiary of Alexandria Real Estate Equities, Inc. to Alexandria Venture Investments, LLC (\"AVI\"), an affiliate of AE7 and another wholly owned subsidiary of Alexandria Real Estate Equities, Inc."},{"field":"shares","element":"transactionShares","label":"F1","text":"These shares have been transferred from Alexandria Equities No. 7, LLC (\"AE7\"), a wholly owned subsidiary of Alexandria Real Estate Equities, Inc. to Alexandria Venture Investments, LLC (\"AVI\"), an affiliate of AE7 and another wholly owned subsidiary of Alexandria Real Estate Equities, Inc."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares have been transferred from Alexandria Equities No. 7, LLC (\"AE7\"), a wholly owned subsidiary of Alexandria Real Estate Equities, Inc. to Alexandria Venture Investments, LLC (\"AVI\"), an affiliate of AE7 and another wholly owned subsidiary of Alexandria Real Estate Equities, Inc."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held directly AE7."}],"balance_after":1243977,"source":{"system":"sec-edgar","filing":"0001035443-20-000079","document":"wf-form4_158568706670079.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000103544320000079/wf-form4_158568706670079.xml","form_type":"4"}},{"id":3191234,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE","position":1,"cik":"0001035443","reported_name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90213,"kind":"organization","name":"Alexandria Venture Investments, LLC","position":2,"cik":"0001722024","reported_name":"Alexandria Venture Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90214,"kind":"organization","name":"Alexandria Equities No. 7, LLC","position":3,"cik":"0001776437","reported_name":"Alexandria Equities No. 7, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-03-31T20:38:04.000Z","date":"2020-03-27","kind":"other","acquired":true,"shares":975000,"ownership":{"direct":false,"nature":"By subsidiary"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares have been transferred from Alexandria Equities No. 7, LLC (\"AE7\"), a wholly owned subsidiary of Alexandria Real Estate Equities, Inc. to Alexandria Venture Investments, LLC (\"AVI\"), an affiliate of AE7 and another wholly owned subsidiary of Alexandria Real Estate Equities, Inc."},{"field":"shares","element":"transactionShares","label":"F1","text":"These shares have been transferred from Alexandria Equities No. 7, LLC (\"AE7\"), a wholly owned subsidiary of Alexandria Real Estate Equities, Inc. to Alexandria Venture Investments, LLC (\"AVI\"), an affiliate of AE7 and another wholly owned subsidiary of Alexandria Real Estate Equities, Inc."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares have been transferred from Alexandria Equities No. 7, LLC (\"AE7\"), a wholly owned subsidiary of Alexandria Real Estate Equities, Inc. to Alexandria Venture Investments, LLC (\"AVI\"), an affiliate of AE7 and another wholly owned subsidiary of Alexandria Real Estate Equities, Inc."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by AVI."}],"balance_after":2146599,"source":{"system":"sec-edgar","filing":"0001035443-20-000079","document":"wf-form4_158568706670079.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000103544320000079/wf-form4_158568706670079.xml","form_type":"4"}},{"id":3518895,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE","position":1,"cik":"0001035443","reported_name":"ALEXANDRIA REAL ESTATE EQUITIES INC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90213,"kind":"organization","name":"Alexandria Venture Investments, LLC","position":2,"cik":"0001722024","reported_name":"Alexandria Venture Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90214,"kind":"organization","name":"Alexandria Equities No. 7, LLC","position":3,"cik":"0001776437","reported_name":"Alexandria Equities No. 7, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2019-05-21T00:59:26.000Z","date":"2019-05-16","kind":"exercise","acquired":false,"shares":1614860,"ownership":{"direct":false,"nature":"By subsidiary"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of Issuer's common stock, without payment of additional consideration, on a one-for-one basis, immediately upon the closing of the Issuer's initial public offering on May 16, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Not applicable"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of Issuer's common stock, without payment of additional consideration, on a one-for-one basis, immediately upon the closing of the Issuer's initial public offering on May 16, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of Issuer's common stock, without payment of additional consideration, on a one-for-one basis, immediately upon the closing of the Issuer's initial public offering on May 16, 2019."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Alexandria Venture Investments, LLC (\"AVI\"), a wholly owned subsidiary of Alexandria Real Estate Equities, Inc. (\"ARE\"). Of these shares, 1,243,977 shares are held by AVI as nominee for Alexandria Equities No. 7, LLC (\"AE7\"), another wholly owned subsidiary of Alexandria Real Estate Equities, Inc.  AVI disclaims beneficial ownership of the shares held as nominee for AE7."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1614860},"source":{"system":"sec-edgar","filing":"0001035443-19-000142","document":"wf-form4_155840035159502.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000103544319000142/wf-form4_155840035159502.xml","form_type":"4"}},{"id":3518894,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE","position":1,"cik":"0001035443","reported_name":"ALEXANDRIA REAL ESTATE EQUITIES INC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90213,"kind":"organization","name":"Alexandria Venture Investments, LLC","position":2,"cik":"0001722024","reported_name":"Alexandria Venture Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90214,"kind":"organization","name":"Alexandria Equities No. 7, LLC","position":3,"cik":"0001776437","reported_name":"Alexandria Equities No. 7, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2019-05-21T00:59:26.000Z","date":"2019-05-16","kind":"exercise","acquired":false,"shares":800716,"ownership":{"direct":false,"nature":"By subsidiary"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of Issuer's common stock, without payment of additional consideration, on a one-for-one basis, immediately upon the closing of the Issuer's initial public offering on May 16, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Not applicable"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of Issuer's common stock, without payment of additional consideration, on a one-for-one basis, immediately upon the closing of the Issuer's initial public offering on May 16, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of Issuer's common stock, without payment of additional consideration, on a one-for-one basis, immediately upon the closing of the Issuer's initial public offering on May 16, 2019."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Alexandria Venture Investments, LLC (\"AVI\"), a wholly owned subsidiary of Alexandria Real Estate Equities, Inc. (\"ARE\"). Of these shares, 1,243,977 shares are held by AVI as nominee for Alexandria Equities No. 7, LLC (\"AE7\"), another wholly owned subsidiary of Alexandria Real Estate Equities, Inc.  AVI disclaims beneficial ownership of the shares held as nominee for AE7."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":800716},"source":{"system":"sec-edgar","filing":"0001035443-19-000142","document":"wf-form4_155840035159502.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000103544319000142/wf-form4_155840035159502.xml","form_type":"4"}},{"id":3518893,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE","position":1,"cik":"0001035443","reported_name":"ALEXANDRIA REAL ESTATE EQUITIES INC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90213,"kind":"organization","name":"Alexandria Venture Investments, LLC","position":2,"cik":"0001722024","reported_name":"Alexandria Venture Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90214,"kind":"organization","name":"Alexandria Equities No. 7, LLC","position":3,"cik":"0001776437","reported_name":"Alexandria Equities No. 7, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-05-21T00:59:26.000Z","date":"2019-05-16","kind":"purchase","acquired":true,"shares":975000,"price":10,"value":9750000.0,"ownership":{"direct":false,"nature":"By subsidiary"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held directly by AE7.  Does not include 1,243,977 shares held directly by AVI as nominee for AE7, as described in footnote (2), which shares may be deemed to be beneficially owned by AE7."}],"balance_after":975000,"source":{"system":"sec-edgar","filing":"0001035443-19-000142","document":"wf-form4_155840035159502.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000103544319000142/wf-form4_155840035159502.xml","form_type":"4"}},{"id":3518892,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE","position":1,"cik":"0001035443","reported_name":"ALEXANDRIA REAL ESTATE EQUITIES INC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90213,"kind":"organization","name":"Alexandria Venture Investments, LLC","position":2,"cik":"0001722024","reported_name":"Alexandria Venture Investments, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":90214,"kind":"organization","name":"Alexandria Equities No. 7, LLC","position":3,"cik":"0001776437","reported_name":"Alexandria Equities No. 7, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-05-21T00:59:26.000Z","date":"2019-05-16","kind":"exercise","acquired":true,"shares":2415576,"ownership":{"direct":false,"nature":"By subsidiary"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of Issuer's common stock, without payment of additional consideration, on a one-for-one basis, immediately upon the closing of the Issuer's initial public offering on May 16, 2019."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Alexandria Venture Investments, LLC (\"AVI\"), a wholly owned subsidiary of Alexandria Real Estate Equities, Inc. (\"ARE\"). Of these shares, 1,243,977 shares are held by AVI as nominee for Alexandria Equities No. 7, LLC (\"AE7\"), another wholly owned subsidiary of Alexandria Real Estate Equities, Inc.  AVI disclaims beneficial ownership of the shares held as nominee for AE7."}],"balance_after":2415576,"source":{"system":"sec-edgar","filing":"0001035443-19-000142","document":"wf-form4_155840035159502.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000103544319000142/wf-form4_155840035159502.xml","form_type":"4"}}]}